Convergent evolution of p38/MAPK activation in hormone resistant prostate cancer mediates pro-survival, immune evasive, and metastatic phenotypes

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Neuroscience

Medicine

Cancer Oncology

Immunology

Show all topics

DOI

10.1101/2020.04.22.050385

License

cc-no